104 results
Page 3 of 6
8-K
EX-99.1
c6r8 ma8h9v0
6 Oct 22
Nurix Therapeutics Reports Third Quarter Fiscal 2022 Financial Results and Provides a Corporate Update
4:10pm
8-K
EX-99.1
a3rcs2r8q g6j
14 Sep 22
Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors
4:01pm
8-K
EX-99.2
07ryhx
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-10.1
dmqsi kd0j1
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-99.1
nyfv3g0yq6t tmle
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
424B5
i4vcg93
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
6vdw432rq80iwr
8 Jul 22
Prospectus supplement for primary offering
4:09pm
8-K
EX-99.1
yeljmlfopj zxhhbbw
7 Jul 22
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update
4:09pm
8-K
EX-99.2
6a6c ciwch7qzwojhqp
26 May 22
Other Events
7:02am
8-K
EX-99.1
3v28ejb9
26 May 22
Other Events
7:02am
8-K
EX-99.1
lv1gppz
7 Apr 22
Nurix Therapeutics Reports Fiscal First Quarter 2022 Financial Results and Provides a Corporate Update
4:08pm